Publications

1. Desai MY, Wolski K, Owens A, Geske JB, Saberi S, Wang A, Sherrid M, Cremer PC, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Smedira NG, Schaff H, Gong Z, Mudarris L, Lampl K, Sehnert AJ, Nissen SE, VALOR-HCM investigators. Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM. Circulation. 2024 Nov 18 [Epub ahead of print]
   View PubMed
2. Alsidawi S, Roehl KM, Farina JM, Arsanjani R, Giudicessi JR, Geske JB, Newman DB, Ackerman MJ, Ommen SR. The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profile. Am Heart J. 2024 Nov; 277:138-141 Epub 2024 July 30
   View PubMed
3. Garmany R, Dasari S, Bos JM, Kim ET, Gluscevic M, Martinez KA, Tester DJ, Dos Remedios C, Maleszewski JJ, Dearani JA, Ommen SR, Geske JB, Giudicessi JR, Ackerman MJ. A multi-omics atlas of sex-specific differences in obstructive hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2024 Nov; 196:26-34 Epub 2024 Sept 08
   View PubMed
4. Abbasi MA, Akiki E, El-Am EA, Geske JB, Bos JM, Ackerman MJ, Attia ZI, Friedman PA, Siontis KC, Newman DB. Artificial intelligence electrocardiography for the evaluation of cardiac involvement in Fabry disease. Curr Probl Cardiol. 2024 Oct 10; 50 (1):102877 [Epub ahead of print]
   View PubMed
5. Suppah M, Abdalla H, Roehl K, Farina J, Arsanjani R, Geske J, Ommen S, Alsidawi S. Sustained Benefits of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: Long-Term Assessment Using Artificial Intelligence-Electrocardiogram and Echocardiographic Data. J Am Soc Echocardiogr. 2024 Oct 9 Epub 2024 Oct 09
   View PubMed
6. Sawma T, Schaff HV, Juarez-Casso F, Rahme S, Todd A, Dearani JA, Bagameri G, Ommen SR, Geske JB. Clinical features and postoperative outcomes in elderly patients undergoing septal myectomy for hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024 Oct 9 Epub 2024 Oct 09
   View PubMed
7. Castrichini M, Alsidawi S, Geske JB, Newman DB, Arruda-Olson AM, Bos JM, Ommen SR, Siontis KC, Ackerman MJ, Giudicessi JR. Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten. Heart Rhythm. 2024 Oct; 21 (10):2065-2067 Epub 2024 Apr 15
   View PubMed
8. Desai MY, Owens A, Wolski K, Geske JB, Saberi S, Wang A, Sherrid M, Cremer PC, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Smedira NG, Schaff H, McErlean E, Sewell C, Zhong Y, Wyrwich KW, Lampl KL, Sehnert AJ, Nissen SE, Spertus JA, VALOR-HCM Investigators. Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial. J Am Coll Cardiol. 2024 Sep 10; 84 (11):1041-1045
   View PubMed
9. Wang C, Zhou W, Geske JB, Zhu Y, Tian J, Liu S, Wang H, Chen X, Tang Q, Deng Y, Liu Y. Clinical Implications of Left Ventricular Apex Mechanics in Patients With Apical Hypertrophic Cardiomyopathy. J Am Soc Echocardiogr. 2024 Sep 7 Epub 2024 Sept 07
   View PubMed
10. Bajona P, Desai MY, Okushi Y, Wolski K, Geske JB, Owens A, Saberi S, Wang A, Cremer PC, Sherrid M, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Lampl KL, Sehnert AJ, Nissen SE, Popovic ZB, VALOR-HCM Investigators. Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial. JACC Cardiovasc Imaging. 2024 Sep 2 Epub 2024 Sept 02
    View PubMed
11. Bajona P, Desai MY, Okushi Y, Gaballa A, Wang Q, Geske JB, Owens AT, Saberi S, Wang A, Cremer PC, Sherrid M, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Lampl KL, Sehnert AJ, Nissen SE, Popovic ZB, VALOR-HCM Investigators. Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial. Circ Cardiovasc Imaging. 2024 Sep; 17 (9):e017185 Epub 2024 Sept 02
    View PubMed
12. Juarez-Casso FM, Schaff HV, Patlolla SH, Todd A, Dearani JA, Geske JB, Ommen SR, Nishimura RA. Aortic valve regurgitation following transaortic septal myectomy for obstructive hypertrophic cardiomyopathy: Incidence and influence on late outcomes. J Thorac Cardiovasc Surg. 2024 Aug; 168 (2):510-518 Epub 2023 May 08
    View PubMed
13. Sawma T, Schaff HV, Geske JB, Dearani JA, Ommen SR. Tricuspid valve surgery following septal myectomy in patients with a cardiac implantable electronic device. JTCVS Open. 2024 Aug; 20:29-36 Epub 2024 June 27
    View PubMed
14. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Outcomes of concomitant myectomy and left ventricular apical aneurysm repair in patients with hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024 Jul; 168 (1):96-103.e1 Epub 2023 Mar 15
    View PubMed
15. Ergi DG, Schaff HV, Ommen SR, Lahr BD, Lee A, Karadhza A, Geske JB. Changes in left ventricular-aortic angulation are associated with the development of obstruction in hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024 Jun 29 Epub 2024 June 29
    View PubMed
16. Burczak DR, Scott CG, Julakanti RR, Kara Balla A, Swain WH, Ismail K, Geske JB, Killu AM, Deshmukh AJ, MacIntyre CJ, Ommen SR, Nkomo VT, Gersh BJ, Noseworthy PA, Siontis KC. Persistence of left atrial thrombus in patients with hypertrophic cardiomyopathy and atrial fibrillation. J Interv Card Electrophysiol. 2024 Jun; 67 (4):731-738 Epub 2023 Sept 16
    View PubMed
17. Abbasi M, Ong KC, Newman DB, Dearani JA, Schaff HV, Geske JB. Obstruction in Hypertrophic Cardiomyopathy: Many Faces. J Am Soc Echocardiogr. 2024 Jun; 37 (6):613-625 Epub 2024 Feb 28
    View PubMed
18. Qamar Y, Schaff HV, Castro-Varela A, Cui H, Dearani JA, Geske JB, Eleid MF, Lee AT, Lahr B, Ommen SR. Outcomes of surgical septal myectomy for obstructive hypertrophic cardiomyopathy after previous septal reduction therapy. J Thorac Cardiovasc Surg. 2024 May 14 [Epub ahead of print]
    View PubMed
19. Malik AA, Saraswati U, Miranda WR, Covington M, Scott CG, Lee AT, Arruda-Olson A, Geske JB, Klarich KW, Anand V. Invasive Cardiac Hemodynamics in Apical Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2024 May 7; 13 (9):e032520 Epub 2024 Apr 30
    View PubMed
20. Alabdaljabar MS, Elhadi M, Geske JB, Klarich KW, Guerrero M, Eleid MF. Sex-Related Differences in Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation. J Am Heart Assoc. 2024 May 7; 13 (9):e032553 Epub 2024 May 03
    View PubMed
21. Roehl K, Suppah M, Geske J, Newman D, Giudicessi J, Ackerman M, Ommen S, Alsidawi S. Effect of Mavacamten on Hypertrophic Cardiomyopathy Patients With Left Ventricular Outflow Tract Obstruction Provoked Only Postexercise or With Amyl Nitrite. J Am Soc Echocardiogr. 2024 May; 37 (5):566-568 Epub 2024 Jan 23
    View PubMed
22. Ahmed EA, Schaff HV, Al-Lami HS, Lahr BD, Dearani JA, Nishimura RA, Ommen SR, Geske JB. Prevalence and influence of pulmonary hypertension in patients with obstructive hypertrophic cardiomyopathy undergoing septal myectomy. J Thorac Cardiovasc Surg. 2024 May; 167 (5):1746-1754.e7 Epub 2022 Sept 07
    View PubMed
23. Suppah M, Roehl K, Lew K, Arsanjani R, Lester S, Ommen S, Geske JB, Siontis KC, Schaff H, Alsidawi S. Assessment of Positive Cardiac Remodeling in Hypertrophic Obstructive Cardiomyopathy Using an AI-ECG Platform in Patients Treated With Mavacamten Mayo Clinic Proceedings Digital Health. 2024.
    
24. Cremer PC, Geske JB, Owens A, Jaber WA, Harb SC, Saberi S, Wang A, Sherrid M, Naidu SS, Schaff HV, Smedira NG, Wang Q, Wolski K, Lampl KL, Sehnert AJ, Nissen SE, Desai MY. Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy: Insight from the VALOR-HCM Study JACC Cardiovasc Imaging. 2024.
    
25. Karim S, Chahal CAA, Sherif AA, Khanji MY, Scott CG, Chamberlain AM, Geske JB, Ommen SR, Gersh BJ, Somers VK, Brady PA, Lin G. Re-evaluating the Incidence and Prevalence of Clinical Hypertrophic Cardiomyopathy: An Epidemiological Study of Olmsted County, Minnesota. Mayo Clin Proc. 2024 Mar; 99 (3):362-374 Epub 2024 Feb 06
    View PubMed
26. Garmany R, Dasari S, Bos JM, Kim ET, Martinez KA, Tester DJ, Dos Remedios C, Maleszewski JJ, Dearani JA, Ommen SR, Geske JB, Giudicessi JR, Ackerman MJ. A Multi-Omics Atlas of Sex-Specific Differences in Obstructive Hypertrophic Cardiomyopathy bioRxiv. 2024.
    
27. Cui H, Schaff HV, Olson TP, Geske JB, Dearani JA, Nishimura RA, Sun D, Ommen SR. Cardiopulmonary exercise test in patients with obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024 Feb; 167 (2):701-710.e3 Epub 2022 May 28
    View PubMed
28. Giudicessi JR, Alsidawi S, Geske JB, Newman DB, Arruda-Olson AM, Bos JM, Ommen SR, Ackerman MJ. Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy. Mayo Clin Proc. 2024 Feb; 99 (2):341-343
    View PubMed
29. Sun D, Schaff HV, Lentz Carvalho J, Nishimura RA, Dearani JA, Ommen SR, Blackshear JL, Geske JB. Improvement in gastrointestinal bleeding after septal myectomy for hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024 Jan; 167 (1):157-163 Epub 2022 Apr 20
    View PubMed
30. Nguyen A, Schaff HV, Calderon-Rojas R, Qrareya MN, Ommen SR, Dearani JA, Todd A, Nishimura RA, Geske JB. Improvement in Sexual Dysfunction in Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy: A Prospective Study. JACC Adv. 2024 Jan; 3 (1):100763 Epub 2023 Dec 13
    View PubMed
31. Abbasi MA, El-Am E, Geske JB, Herrmann J. Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy Mayo Clinic Proceedings. 2023.
    
32. Desai MY, Owens A, Wolski K, Geske JB, Saberi S, Wang A, Sherrid M, Cremer PC, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Smedira NG, Schaff H, McErlean E, Sewell C, Mudarris L, Gong Z, Lampl K, Sehnert AJ, Nissen SE. Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial. JAMA Cardiol. 2023 Oct 1; 8 (10):968-977
    View PubMed
33. Hirschfeld CB, Dorbala S, Shaw LJ, Villines TC, Choi AD, Better N, Cerci RJ, Karthikeyan G, Vitola JV, Williams MC, Al-Mallah M, Berman DS, Bernheim A, Biederman RW, Bravo PE, Budoff MJ, Bullock-Palmer RP, Chen MY, DiLorenzo MP, Doukky R, Ferencik M, Geske JB, Hage FG, Hendel RC, Koweek L, Murthy VL, Narula J, Rodriguez Lozano PF, Shah NR, Shah A, Soman P, Thompson RC, Wolinsky D, Cohen YA, Malkovskiy E, Randazzo MJ, Lopez-Mattei J, Parwani P, Shetty M, Pascual TNB, Pynda Y, Dondi M, Paez D, Einstein AJ, INCAPS COVID 2 Investigators Group. Cardiovascular Testing in the United States during the COVID-19 Pandemic: Volume Recovery and Worldwide Comparison. Radiol Cardiothorac Imaging. 2023 Oct; 5 (5):e220288 Epub 2023 Sept 21
    View PubMed
34. Siontis KC, Ommen SR, Geske JB. Art and science of risk stratification of sudden cardiac death in hypertrophic cardiomyopathy: Current state, unknowns, and future directions. Prog Cardiovasc Dis. 2023 Sep-Oct; 80:25-31 Epub 2023 Aug 14
    View PubMed
35. Cui H, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Newman DB, Ommen SR. Preoperative left ventricular longitudinal strain predicts outcome of septal myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2023 Aug; 166 (2):492-500.e2 Epub 2021 Oct 06
    View PubMed
36. Bois JP, Ayoub C, Geske JB, Wong YW, Abbasi MA, Foley TA, Mulvagh SL, Scott CG, Ommen SR, Pellikka PA. Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy. Mayo Clin Proc Innov Qual Outcomes. 2023 Aug; 7(4):309-319. Epub 2023 Jul 19.
    View PubMed
37. Alabdaljabar MS, Cendrowski EE, Nishimura RA, Miranda WR, Geske JB, Rihal CS, Eleid MF. Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. Circ Cardiovasc Interv. 2023 Aug; 16(8):e013068. Epub 2023 Aug 15.
    View PubMed
38. Burczak DR, Julakanti RR, Kara Balla A, Scott CG, Geske JB, Ommen SR, Nkomo VT, Gersh BJ, Noseworthy PA, Siontis KC. Risk of Left Atrial Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. J Am Coll Cardiol 2023 Jul 18; 82 (3):278-279
    View PubMed
39. Lampert R, Ackerman MJ, Marino BS, Burg M, Ainsworth B, Salberg L, Tome Esteban MT, Ho CY, Abraham R, Balaji S, Barth C, Berul CI, Bos M, Cannom D, Choudhury L, Concannon M, Cooper R, Czosek RJ, Dubin AM, Dziura J, Eidem B, Emery MS, Estes NAM, Etheridge SP, Geske JB, Gray B, Hall K, Harmon KG, James CA, Lal AK, Law IH, Li F, Link MS, McKenna WJ, Molossi S, Olshansky B, Ommen SR, Saarel EV, Saberi S, Simone L, Tomaselli G, Ware JS, Zipes DP, Day SM, LIVE Consortium. Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2023 Jun 1; 8 (6):595-605
    View PubMed
40. Garmany R, Bos JM, Ommen SR, Ackerman MJ, Geske JB. Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care. ESC Heart Fail. 2023 Jun; 10 (3):1919-1927 Epub 2023 Mar 28
    View PubMed
41. Desai MY, Owens A, Geske JB, Wolski K, Saberi S, Wang A, Sherrid M, Cremer PC, Naidu SS, Smedira NG, Schaff H, McErlean E, Sewell C, Balasubramanyam A, Lampl K, Sehnert AJ, Nissen SE. Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks. Circulation. 2023 Mar 14; 147 (11):850-863 Epub 2022 Nov 06
    View PubMed
42. Engrav SK, Geske JB, Siontis KC. Determining the cause of cardiac arrest: artificial intelligence at the bedside. Eur Heart J Digit Health. 2023 Mar; 4 (2):136-137 Epub 2023 Jan 18
    View PubMed
43. Burczak DR, Newman DB, Jaffe AS, Ackerman MJ, Ommen SR, Geske JB. High-Sensitivity Cardiac Troponin T Elevation in Hypertrophic Cardiomyopathy Is Associated With Ventricular Arrhythmias. Mayo Clin Proc. 2023 Mar; 98 (3):410-418
    View PubMed
44. Newman DB, Garmany R, Contreras AM, Bos JM, Johnson JN, Geske JB, Allison TG, Ommen SR, Ackerman MJ. Cardiopulmonary Exercise Testing in Athletes With Hypertrophic Cardiomyopathy. Am J Cardiol. 2023 Feb 15; 189:49-55 Epub 2022 Dec 09
    View PubMed
45. Lee JC, Geske JB, Narang A, Khalique OK, Choi AD, Sun YP, Cavalcante JL, Pinto DS, Gafoor SA, Jagasia DH, DiCarli MF, Villines TC, Little SH, Hahn RT, Wang DD. Structural Heart Imaging Survey Highlights: Training, Challenges, and Practice Patterns in Interventional Imaging. JACC Cardiovasc Imaging 2023 Feb; 16 (2):255-258 Epub 2022 Nov 16
    View PubMed
46. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. In-Hospital Outcomes of Acute Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy. Mayo Clin Proc Innov Qual Outcomes. 2023 Feb; 7 (1):45-50 Epub 2022 Dec 30
    View PubMed
47. Patlolla SH, Schaff HV, Nishimura RA, Eleid MF, Geske JB, Ommen SR. Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2023 Jan 3; 12 (1):e026661 Epub 2022 Dec 24
    View PubMed
48. Lentz Carvalho J, Schaff HV, Nishimura RA, Ommen SR, Geske JB, Lahr BD, Newman DB, Dearani JA. Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy? J Thorac Cardiovasc Surg. 2023 Jan; 165 (1):79-87.e1 Epub 2021 Jan 21
    View PubMed
49. Pham JH, Giudicessi JR, Tweet MS, Boucher L, Newman DB, Geske JB. Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report. Front Cardiovasc Med. 2023; 10:1167256 Epub 2023 Apr 27
    View PubMed
50. Anand V, Covington MK, Saraswati U, Scott CG, Lee AT, Frantz RP, Anavekar NS, Geske JB, Arruda-Olson AM, Klarich KW. Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathy. Front Cardiovasc Med. 2023; 10:1288747 Epub 2024 Jan 11
    View PubMed
51. Ismayl M, Abbasi MA, Marar R, Geske JB, Gersh BJ, Anavekar NS. Mavacamten Treatment for Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Probl Cardiol. 2023 Jan; 48 (1):101429 Epub 2022 Sept 24
    View PubMed
52. Batchelor WB, Anwaruddin S, Wang DD, Perpetua EM, Krishnaswami A, Velagapudi P, Wyman JF, Fullerton D, Keegan P, Phillips A, Ross L, Maini B, Bernacki G, Panjrath GS, Lee J, Geske JB, Welt F, Thakker PD, Deswal A, Park K, Mack MJ, Leon M, Lewis S, Holmes D. The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future Challenges. JACC Adv. 2023 Jan; 2 (1):100160 Epub 2023 Jan 11
    View PubMed
53. Cui H, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Ommen SR. Latent outflow tract obstruction in hypertrophic cardiomyopathy: Clinical characteristics and outcomes of septal myectomy. J Thorac Cardiovasc Surg. 2022 Dec; 164 (6):1863-1869.e1 Epub 2020 Dec 10
    View PubMed
54. Cremer PC, Geske JB, Owens A, Jaber WA, Harb SC, Saberi S, Wang A, Sherrid M, Naidu SS, Schaff H, Smedira NG, Wang Q, Wolski K, Lampl KL, Sehnert AJ, Nissen SE, Desai MY. Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study. Circ Cardiovasc Imaging. 2022 Dec; 15 (12):e014986 Epub 2022 Nov 06
    View PubMed
55. Burczak D, Newman DB, Jaffe AS, Ackerman MJ, Ommen SR, Geske JB. High Sensitivity Troponin T Elevation in Hypertrophic Cardiomyopathy is Associated with Ventricular Arrhythmias. Mayo Clinic Proceedings In Press. 2022.
    
56. Maanja M, Noseworthy PA, Geske JB, Ackerman MJ, Arruda-Olson AM, Ommen SR, Attia ZI, Friedman PA, Siontis KC. Tandem deep learning and logistic regression models to optimize hypertrophic cardiomyopathy detection in routine clinical practice. Cardiovasc Digit Health J. 2022 Dec; 3(6):289-296. Epub 2022 Oct 22.
    
57. Geske JB, Stephens EH, Dearani JA. Hypertrophic cardiomyopathy with extreme outflow tract obstruction. Eur Heart J. 2022 Nov 7; 43 (42):4518
    View PubMed
58. Grimaldo AB, McConn K, Maleszewski JJ, Rowse PG, Geske JB. Malignant Left Ventricular Outflow Tract Obstruction: A Reason to Operate? JACC Case Rep. 2022 Nov 2; 4 (21):1414-1417 Epub 2022 Nov 02
    View PubMed
59. Patlolla SH, Schaff HV, Nishimura RA, Geske JB, Lahr BD, Lee AT, Eleid MF, Ommen SR, Dearani JA. Mitral Annular Calcification in Obstructive Hypertrophic Cardiomyopathy: Prevalence and Outcomes. Ann Thorac Surg. 2022 Nov; 114 (5):1679-1687 Epub 2021 Nov 22
    View PubMed
60. Cui H, Schaff HV, Geske JB, Lahr BD, Dearani JA, Nishimura RA, Ommen SR. Early septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2022 Nov; 164 (5):1502-1509.e5 Epub 2020 Oct 28
    View PubMed
61. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ducharme MT, Ommen SR. Posterior Wall Thickness Associates With Survival Following Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. JACC Heart Fail. 2022 Nov; 10 (11):831-837 Epub 2022 Sept 07
    View PubMed
62. Dewaswala N, Chen D, Bhopalwala H, Kaggal VC, Murphy SP, Bos JM, Geske JB, Gersh BJ, Ommen SR, Araoz PA, Ackerman MJ, Arruda-Olson AM. Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports. BMC Med Inform Decis Mak. 2022 Oct 18; 22 (1):272
    View PubMed
63. Cheung M, Husain A, Du D, Li COY, Parker J, Weissler-Snir A, Geske JB, Ong K, Laksman Z. International Practice Patterns in the Detection and Management of Arrhythmias in Patients With Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2022 Oct 04; 11(19):e027385.
    
64. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Transapical Ventricular Remodeling for Hypertrophic Cardiomyopathy With Systolic Cavity Obliteration. Ann Thorac Surg. 2022 Oct; 114 (4):1284-1289 Epub 2022 Mar 23
    View PubMed
65. Krithika R, Geske JB, Villarraga HR, Crestanello J. Concrete proof of Murphy's law: a case report of intracardiac cement embolization. Eur Heart J Case Rep. 2022 Oct; 6 (10):ytac386 Epub 2022 Sept 16
    View PubMed
66. Sun D, Schaff HV, Somers VK, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Association of Preoperative Sleep-Disordered Breathing With Functional Status After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. CJC Open. 2022 Oct; 4 (10):848-853 Epub 2022 July 11
    View PubMed
67. Calderon-Rojas R, Nguyen A, Nishimura RA, Geske JB, Ommen SR, King KS, Lee AT, Dearani JA, Schaff HV. Is there referral bias in outcomes of septal myectomy for hypertrophic cardiomyopathy? J Thorac Cardiovasc Surg. 2022 Sep; 164 (3):881-891 Epub 2020 Oct 09
    View PubMed
68. Oberoi M, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Surgical Management of Hypertrophic Cardiomyopathy Complicated by Infective Endocarditis. Ann Thorac Surg. 2022 Sep; 114 (3):744-749 Epub 2022 Feb 01
    View PubMed
69. Sun D, Schaff HV, Van Houten HK, Nguyen A, Sangaralingham LR, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Longitudinal Cost of Septal Myectomy Versus Alcohol Septal Ablation for Hypertrophic Cardiomyopathy. Mayo Clin Proc. 2022 Sep; 97 (9):1656-1663
    View PubMed
70. Naser JA, Crestanello JA, Nkomo VT, Luis SA, Thaden JJ, Geske JB, Anderson JH, Sinak LJ, Michelena HI, Pislaru SV, Padang R. Immobile Leaflets at Time of Bioprosthetic Valve Implantation: A Novel Risk Factor for Early Bioprosthetic Failure: A Novel Risk Factor for Early Bioprosthetic Failure. Heart Lung Circ. 2022 Aug; 31 (8):1166-1175 Epub 2022 Mar 24
    View PubMed
71. Desai MY, Owens A, Geske JB, Wolski K, Naidu SS, Smedira NG, Cremer PC, Schaff H, McErlean E, Sewell C, Li W, Sterling L, Lampl K, Edelberg JM, Sehnert AJ, Nissen SE. Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy. J Am Coll Cardiol. 2022 Jul 12; 80 (2):95-108
    View PubMed
72. Gweun J, Thomas SC, Geske JB. Exuberant late gadolinium enhancement in hypertrophic cardiomyopathy as a precursor to 'burn out'. Eur Heart J Case Rep. 2022 Jun; 6 (6):ytac243 Epub 2022 June 24
    View PubMed
73. Wen S, Pislaru C, Ommen SR, Ackerman MJ, Pislaru SV, Geske JB. Right Ventricular Enlargement and Dysfunction Are Associated With Increased All-Cause Mortality in Hypertrophic Cardiomyopathy. Mayo Clin Proc. 2022 Jun; 97 (6):1123-1133 Epub 2022 Apr 27
    View PubMed
74. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Newman DB, Ommen SR. Patient-Reported Atrial Fibrillation After Septal Myectomy for Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2022 Jun; 113 (6):1918-1924 Epub 2021 Oct 14
    View PubMed
75. Einstein AJ, Hirschfeld C, Williams MC, Vitola JV, Better N, Villines TC, Cerci R, Shaw LJ, Choi AD, Dorbala S, Karthikeyan G, Lu B, Sinitsyn V, Ansheles AA, Kudo T, Bucciarelli-Ducci C, Norgaard BL, Maurovich-Horvat P, Campisi R, Milan E, Louw L, Allam AH, Bhatia M, Sewanan L, Malkovskiy E, Cohen Y, Randazzo M, Narula J, Morozova O, Pascual TNB, Pynda Y, Dondi M, Paez D, Incaps Covid Investigators Group, Geske JB. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19 J Am Coll Cardiol. 2022.
    
76. Chen D, Bhopalwala H, Dewaswala N, Arunachalam SP, Enayati M, Farahani NZ, Pasupathy K, Lokineni S, Bos JM, Noseworthy PA, Arsanjani R, Erickson BJ, Geske JB, Ackerman MJ, Araoz PA, Arruda-Olson AM. Deep Neural Network for Cardiac Magnetic Resonance Image Segmentation. J Imaging. 2022 May 23; 8 (5)
    View PubMed
77. Ahmed EA, Schaff HV, Geske JB, Lee AT, King KS, Dearani JA, Nishimura RA, Ommen SR. Optimal Management of Mitral Regurgitation Due to Ruptured Mitral Chordae Tendineae in Patients With Hypertrophic Cardiomyopathy. Semin Thorac Cardiovasc Surg. 2022 May 20 [Epub ahead of print]
    View PubMed
78. Rosenbaum AN, Geske JB, Stulak JM, Kushwaha SS, Clavell AL, Behfar A. Left Ventricular Hemodynamics and Relationship With Myocardial Recovery and Optimization in Patients Supported on CF-LVAD Therapy. J Card Fail. 2022 May; 28 (5):799-806 Epub 2021 Dec 17
    View PubMed
79. Du D, Li COY, Ong K, Parsa A, Weissler-Snir A, Geske JB, Laksman Z. Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy. CJC Open. 2022 Apr; 4 (4):406-415 Epub 2022 Jan 07
    View PubMed
80. Sun D, Schaff HV, McKenzie TJ, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Safety of Bariatric Surgery in Obese Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2022 Mar 15; 167:93-97. Epub 2022 Jan 03.
    
81. Peng L, Burczak DR, Newman DB, Geske JB. Repetitive Squat-to-Stand Provocation of Dynamic Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy. J Am Soc Echocardiogr. 2022 Mar; 35 (3):323-326 Epub 2021 Nov 06
    View PubMed
82. Patlolla SH, Schaff HV, Nishimura RA, Geske JB, Dunlay SM, Ommen SR. Sex and Race Disparities in Hypertrophic Cardiomyopathy: Unequal Implantable Cardioverter-Defibrillator Use During Hospitalization. Mayo Clin Proc. 2022 Mar; 97 (3):507-518 Epub 2021 Dec 07
    View PubMed
83. Carvalho JL, Ashikhmina E, Abel MD, Viehman JK, Lahr BD, Geske JB, Schaff HV. Hypertrophic Obstructive Cardiomyopathy: Discrepancy Between Hemodynamic Measurements in the Cardiac Laboratory and Operating Room Is to Be Expected. J Cardiothorac Vasc Anesth. 2022 Feb; 36 (2):422-428 Epub 2021 May 24
    View PubMed
84. Ye Z, Smith MM, Jouni H, Geske JB, Carney SA, Urina-Jassir M, Schaff HV, Enriquez-Sarano M, Michelena HI. Mitral Valve Cleft-like Indentations in Hypertrophic Obstructive Cardiomyopathy: Insights From Intraoperative Three-Dimensional Transesophageal Echocardiography. J Cardiothorac Vasc Anesth. 2022 Feb; 36 (2):429-436 Epub 2021 May 25
    View PubMed
85. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR. Impact of Body Mass Index on Outcome of Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2022 Feb; 113 (2):519-526 Epub 2021 Mar 25
    View PubMed
86. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy. JTCVS Tech. 2022 Feb; 11:21-26 Epub 2021 Nov 01
    View PubMed
87. Weerasekare JM, Geske JB. 'Heart within a heart': echocardiographic assessment of hypertrophic cardiomyopathy. Eur Heart J. 2021 Dec 7; 42 (46):4775
    View PubMed
88. Siontis KC, Bhopalwala H, Dewaswala N, Scott CG, Noseworthy PA, Geske JB, Ommen SR, Nishimura RA, Ackerman MJ, Friedman PA, Arruda-Olson AM. Natural language processing of implantable cardioverter-defibrillator reports in hypertrophic cardiomyopathy: A paradigm for longitudinal device follow-up. Cardiovasc Digit Health J. 2021 Oct; 2 (5):264-269 Epub 2021 May 20
    View PubMed
89. Cui H, Schaff HV, Somers VK, Nishimura RA, Dearani JA, Geske JB, King KS, Ommen SR. Sleep Disordered Breathing and Mortality in Patients With Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myectomy. Mayo Clin Proc. 2021 Sep; 96 (9):2323-2331 Epub 2021 July 03
    View PubMed
90. Desai MY, Wolski K, Owens A, Naidu SS, Geske JB, Smedira NG, Schaff H, Lampl K, McErlean E, Sewell C, Zhang D, Edelberg JM, Sehnert AJ, Nissen SE. Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy. Am Heart J. 2021 Sep; 239:80-89 Epub 2021 May 24
    View PubMed
91. Ezzeddine FM, Giudicessi JR, Maleszewski JJ, Lin PT, Borlaug BA, Geske JB. Unmasking Hydroxychloroquine Cardiotoxicity in a Patient With Heart Failure and Chronotropic Incompetence. JACC Case Rep. 2021 Jul 7; 3 (7):997-1001 Epub 2021 May 26
    View PubMed
92. Jain CC, Miranda WR, Geske JB, Schaff HV, Nishimura RA. Echocardiographic Characteristics of Severe Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy. J Am Soc Echocardiogr. 2021 Jul; 34 (7):798-801 Epub 2021 Apr 02
    View PubMed
93. Nguyen A, Schaff HV, Ommen SR, Gersh BJ, Dearani JA, Geske JB, Lahr BD, Nishimura RA. Late Health Status of Patients Undergoing Myectomy for Obstructive Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2021 Jun; 111 (6):1867-1875 Epub 2020 Oct 27
    View PubMed
94. Cui H, Schaff HV, Lentz Carvalho J, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Lee AT, Bos JM, Ackerman MJ, Ommen SR, Maleszewski JJ. Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2021 May 4; 77 (17):2159-2170
    View PubMed
95. Zanjirani Farahani N, Enayati MSundaram DSB , Damani DN, Kaggal VC, Zacher AL, Geske JB, Kane G, Arunachalam SP, Pasupathy KS, Arruda-Olson A. Application of Machine Learning For Detection of Hypertrophic Cardiomyopathy Patients From Echocardiogram Measurements Proceedings of the Design of Medical Devices Conference. 2021.
    
96. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Transapical Septal Myectomy for Hypertrophic Cardiomyopathy With Midventricular Obstruction. Ann Thorac Surg. 2021 Mar; 111 (3):836-844 Epub 2020 Aug 06
    View PubMed
97. Cui H, Schaff HV, Dearani JA, Lahr BD, Viehman JK, Geske JB, Nishimura RA, Ommen SR. Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy? J Thorac Cardiovasc Surg. 2021 Mar; 161 (3):997-1006.e3 Epub 2020 Aug 25
    View PubMed
98. Bhopalwala H, Dewaswala N, Liu S, Scott CG, Welper JM, Akinnusotu O, Bos JM, Ommen SR, Ackerman MJ, Pellikka PA, Geske JB, Noseworthy P, Arruda-Olson AM. Conversion of left atrial volume to diameter for automated estimation of sudden cardiac death risk in hypertrophic cardiomyopathy. Echocardiography. 2021 Feb; 38 (2):183-188 Epub 2020 Dec 16
    View PubMed
99. Ito S, Dhesi S, Miranda WR, Geske JB, Anavekar NS, Morant K, Rihal CS, Eleid MF, Oh JK. Assessment of left ventricular filling pressure with Doppler velocities across the patent foramen ovale. J Echocardiogr. 2021 Jan 12 [Epub ahead of print]
    View PubMed
100. Alabdaljabar MS, Turgul G, Arruda-Olson AM, Geske JB. Radiolucent Mechanical Valve: Chest Radiography Conundrum. J Saudi Heart Assoc. 2021; 33(4):294-295. Epub 2021 Oct 15.
     View PubMed
101. Peng LT, Newman DB, Geske JB. Squat-to-stand provocation of dynamic left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: a case report. Eur Heart J Case Rep. 2021 Jan; 5(1):ytaa450. Epub 2020 Dec 28.
     
102. Mathew J, Nguyen A, Nishimura RA, Geske JB, Dearani JA, Ommen SR, Lahr BD, Schaff HV. Septal Myectomy in patients with previous coronary revascularization - hypertrophic cardiomyopathy masquerading as ischemic heart disease. Int J Cardiol. 2020 Nov 15; 319:97-100 Epub 2020 June 20
     View PubMed
103. Zoghbi WA, DiCarli MF, Blankstein R, Choi AD, Dilsizian V, Flachskampf FA, Geske JB, Grayburn PA, Jaffer FA, Kwong RY, Leipsic JA, Marwick TH, Nagel E, Nieman K, Raman SV, Salerno M, Sengupta PP, Shaw LJ, Chandrashekhar YS, ACC Imaging Council. Multimodality Cardiovascular Imaging in the Midst of the COVID-19 Pandemic: Ramping Up Safely to a New Normal. JACC Cardiovasc Imaging. 2020 Jul; 13 (7):1615-1626 Epub 2020 June 12
     View PubMed
104. Mathew J, Geske JB, Luis SA, Schaff HV. An unusual coronary embolus in a patient with prosthetic endocarditis. Eur Heart J. 2020 Jun 14; 41 (23):2179
     View PubMed
105. Guerrero ME, Killu AM, Gonzalez-Quesada C, Bagameri G, Eleid MF, Alkhouli M, Geske J, Williamson E, Asirvatham S, Rihal C. Pre-Emptive Radiofrequency Septal Ablation to Decrease the Risk of Left Ventricular Outflow Tract Obstruction After TMVR. JACC Cardiovasc Interv. 2020 May 11; 13 (9):1129-1132 Epub 2020 Mar 25
     View PubMed
106. Choi AD, Geske JB, Lopez-Mattei JC, Parwani P, Wang DD, Winchester DE, Sengupta PP, Zoghbi WA, Shaw LJ, Chandrashekhar YS, Blankstein R. Cardiovascular Imaging Through the Prism of Modern Metrics. JACC Cardiovasc Imaging. 2020 May; 13 (5):1256-1269 Epub 2020 Mar 16
     View PubMed
107. Bonura ED, Bos JM, Abdelsalam MA, Araoz PA, Ommen SR, Ackerman MJ, Geske JB. Cardiac Magnetic Resonance Imaging Features in Hypertrophic Cardiomyopathy Diagnosed at <21 Years of Age. Am J Cardiol. 2020 Apr 15; 125 (8):1249-1255 Epub 2020 Jan 28
     View PubMed
108. Nguyen A, Schaff HV, Sedeek AF, Geske JB, Dearani JA, Ommen SR, Lahr BD, Viehman JK, Nishimura RA. Septal Myectomy and Concomitant Coronary Artery Bypass Grafting for Patients With Hypertrophic Cardiomyopathy and Coronary Artery Disease. Mayo Clin Proc. 2020 Mar; 95 (3):521-525
     View PubMed
109. Geske JB, Driver CN, Yogeswaran V, Ommen SR, Schaff HV. Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy. Am Heart J. 2020 Mar; 221:159-164 Epub 2019 Dec 18
     View PubMed
110. Ryu AJ, Kane GC, Pislaru SV, Lekhakul A, Geske JB, Luis SA, Michelena HI, Nkomo VT, Thaden JJ, Sinak LJ. Bleeding Complications of Ultrasound-Guided Pericardiocentesis in the Presence of Coagulopathy or Thrombocytopenia. J Am Soc Echocardiogr. 2020 Mar; 33 (3):399-401 Epub 2020 Jan 17
     View PubMed
111. Ko WY, Siontis KC, Attia ZI, Carter RE, Kapa S, Ommen SR, Demuth SJ, Ackerman MJ, Gersh BJ, Arruda-Olson AM, Geske JB, Asirvatham SJ, Lopez-Jimenez F, Nishimura RA, Friedman PA, Noseworthy PA. Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram. J Am Coll Cardiol. 2020 Feb 25; 75 (7):722-733
     View PubMed
112. El-Sabawi B, Nishimura RA, Barsness GW, Cha YM, Geske JB, Eleid MF. Temporal Occurrence of Arrhythmic Complications After Alcohol Septal Ablation. Circ Cardiovasc Interv. 2020 Feb; 13 (2):e008540 Epub 2020 Jan 24
     View PubMed
113. Nguyen A, Schaff HV, Nishimura RA, Geske JB, Dearani JA, King KS, Ommen SR. Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure. J Thorac Cardiovasc Surg. 2020 Jan; 159 (1):145-152 Epub 2019 Apr 05
     View PubMed
114. Patel SI, Shamoun FE, Esser H, Parthasarathy S, Ackerman MJ, Geske JB, Ommen SR, Love WT, Somers VK, Chahal CA, Bos JM, Cha SS, Lester SJ. Sleep Disordered Breathing in Hypertrophic Cardiomyopathy Sleep and Vigilance. 2019; 4.1(4.1):3-9. Epub 2020 Jun 01.
     
115. Cullen MW, Geske JB, Anavekar NS, McAdams JA, Beliveau ME, Ommen SR, Nishimura RA. Reinvigorating Continuing Medical Education: Meeting the Challenges of the Digital Age. Mayo Clin Proc. 2019 Dec; 94 (12):2501-2509
     View PubMed
116. Jain CC, Newman DB, Geske JB. Mitral Valve Disease in Hypertrophic Cardiomyopathy:Evaluation and Management. Curr Cardiol Rep. 2019 Oct 31; 21 (11):136
     View PubMed
117. Meghji Z, Nguyen A, Miranda WR, Geske JB, Schaff HV, Peck DS, Newman DB. Surgical septal myectomy for relief of dynamic obstruction in Anderson-Fabry Disease. Int J Cardiol. 2019 Oct 1; 292:91-94 Epub 2019 June 19
     View PubMed
118. Nguyen A, Schaff HV, Nishimura RA, Geske JB, Ackerman MJ, Bos JM, Dearani JA, Ommen SR. Survival After Myectomy for Obstructive Hypertrophic Cardiomyopathy: What Causes Late Mortality? Ann Thorac Surg. 2019 Sep; 108 (3):723-729 Epub 2019 Apr 09
     View PubMed
119. Adigun RO, Baddour LM, Geske JB. A case report of Histoplasma capsulatum prosthetic valve endocarditis: an extremely rare presentation with characteristic findings. Eur Heart J Case Rep. 2019 Sep; 3 (3):ytz127 Epub 2019 Sept 17
     View PubMed
120. Cui H, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR. Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2019 Aug 6; 74 (5):645-655
     View PubMed
121. Moon S, Liu S, Scott CG, Samudrala S, Abidian MM, Geske JB, Noseworthy PA, Shellum JL, Chaudhry R, Ommen SR, Nishimura RA, Liu H, Arruda-Olson AM. Automated extraction of sudden cardiac death risk factors in hypertrophic cardiomyopathy patients by natural language processing. Int J Med Inform. 2019 Aug; 128:32-38 Epub 2019 May 13
     View PubMed
122. Davies DR, Bhatia S, Geske JB. 58-Year-Old Asymptomatic Man With Left Ventricular Hypertrophy. Mayo Clin Proc. 2019 Jul; 94 (7):1330-1333
     View PubMed
123. Ryu AJ, Geske JB. 63-Year-Old Man With Fever, Chills, and Myalgias. Mayo Clin Proc. 2019 May; 94 (5):882-886 Epub 2019 Mar 29
     View PubMed
124. Wang Dee Dee, Geske JB, Choi Andrew D, Lee James C, Khalique Omar K, Gafoor Sameer, Atianzar Kimberly, Blanke Phillip, Little Stephen H, Sorajja Paul, O’Neill William W, Cavalcante João L. Interventional Imaging for Structural Heart Disease: Challenges and New Frontiers of an Emerging Multi-disciplinary Field Structural Heart. 2019; 3(3):187-200. Epub 2019 Mar 18.
     
125. Faza Nadeen, Wang Dee, Cavalcante Joao, Choi Andrew, Geske JB, Little Stephen. Interventional Imagers: The Conductors of the Heart Team Orchestra Diagnostic and Interventional Cardiology. April 24, 2019; (Structural Heart).
     
126. Newman DB, Bois JP, Geske JB. Evaluation of the patient with incidental left ventricular hypertrophy on echocardiography Cardiovascular Innovations And Applications. 2019 Apr 1; 4 (1):43-51
     
127. Vallabhajosyula S, Geske JB, Kumar M, Kashyap R, Kashani K, Jentzer JC. Doppler-defined pulmonary hypertension in sepsis and septic shock. J Crit Care. 2019 Apr; 50:201-206 Epub 2018 Dec 08
     View PubMed
128. Geske JB, Gersh BJ. The hypertrophic cardiomyopathy paradox: better with age. Eur Heart J 2019 Mar 21; 40 (12):994-996
     View PubMed
129. Meghji Z, Nguyen A, Fatima B, Geske JB, Nishimura RA, Ommen SR, Lahr BD, Dearani JA, Schaff HV. Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. JAMA Cardiol. 2019 Mar 1; 4 (3):237-245
     View PubMed
130. Vallabhajosyula S, Rayes HA, Sakhuja A, Murad MH, Geske JB, Jentzer JC. Global Longitudinal Strain Using Speckle-Tracking Echocardiography as a Mortality Predictor in Sepsis: A Systematic Review. J Intensive Care Med. 2019 Feb; 34 (2):87-93 Epub 2018 Mar 18
     View PubMed
131. Patel SI, Ackerman MJ, Shamoun FE, Geske JB, Ommen SR, Love WT, Cha SS, Bos JM, Lester SJ. QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy. Acta Cardiol. 2019 Feb; 74 (1):53-58 Epub 2018 Mar 07
     View PubMed
132. Newman DB, Miranda WR, Matern D, Peck DS, Geske JB, Maleszewski JJ, Ommen SR, Ackerman MJ. Cost Efficacy of alpha-Galactosidase A Enzyme Screening for Fabry Disease. Mayo Clin Proc. 2019 Jan; 94 (1):84-88
     View PubMed
133. Nguyen A, Schaff HV, Hang D, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort. J Thorac Cardiovasc Surg. 2019 Jan; 157 (1):306-315.e3 Epub 2018 Sept 05
     View PubMed
134. Wang DD, Geske J, Choi AD, Khalique O, Lee J, Atianzar K, Wu I, Blanke P, Gafoor S, Cavalcante JL. Navigating a Career in Structural Heart Disease Interventional Imaging. JACC Cardiovasc Imaging 2018 Dec; 11 (12):1928-1930 Epub 2018 Sept 12
     View PubMed
135. Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Lahr BD, Ommen SR. Determinants of Reverse Remodeling of the Left Atrium After Transaortic Myectomy. Ann Thorac Surg. 2018 Aug; 106 (2):447-453 Epub 2018 Apr 19
     View PubMed
136. Meghji Z, Nguyen A, Geske JB, Schaff HV. Myectomy and Left Atrial-to-Left Ventricular Conduit for Severe Calcific Mitral Stenosis and Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2018 Jul; 106 (1):e21-e23 Epub 2018 Feb 27
     View PubMed
137. Egbe AC, Khan AR, Boler A, Said SM, Geske JB, Miranda WR, Akintoye E, Connolly HM, Warnes CA, Oh JK. Role of diastolic function indices in the risk stratification of patients with mixed aortic valve disease. Eur Heart J Cardiovasc Imaging. 2018 Jun 1; 19 (6):668-674
     View PubMed
138. Calvin AD, Aggarwal NR, Murad MH, Shi Q, Elamin MB, Geske JB, Fernandez-Balsells MM, Albuquerque FN, Lampropulos JF, Erwin PJ, Smith SA, Montori VM. Erratum. Aspirin for the Primary Prevention of Cardiovascular Events. A Systematic Review and Meta-Analysis Comparing Patients With and Without Diabetes. Diabetes Care 2009;32:2300-2306. Diabetes Care. 2018 Jun; 41 (6):1321-1322 Epub 2018 Apr 23
     View PubMed
139. Geske JB, Ommen SR, Gersh BJ. Hypertrophic Cardiomyopathy: Clinical Update. JACC Heart Fail. 2018 May; 6 (5):364-375 Epub 2018 Apr 11
     View PubMed
140. Blackshear JL, Safford RE, Thomas CS, Bos JM, Ackerman MJ, Geske JB, Ommen SR, Shapiro BP, Johns GS. Platelet Function Analyzer 100 and Brain Natriuretic Peptide as Biomarkers in Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 Mar 15; 121 (6):768-774 Epub 2017 Dec 25
     View PubMed
141. O'Mahony C, Jichi F, Ommen SR, Christiaans I, Arbustini E, Garcia-Pavia P, Cecchi F, Olivotto I, Kitaoka H, Gotsman I, Carr-White G, Mogensen J, Antoniades L, Mohiddin SA, Maurer MS, Tang HC, Geske JB, Siontis KC, Mahmoud KD, Vermeer A, Wilde A, Favalli V, Guttmann OP, Gallego-Delgado M, Dominguez F, Tanini I, Kubo T, Keren A, Bueser T, Waters S, Issa IF, Malcolmson J, Burns T, Sekhri N, Hoeger CW, Omar RZ, Elliott PM. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM). Circulation. 2018 Mar 6; 137 (10):1015-1023 Epub 2017 Nov 30
     View PubMed
142. Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Lahr BD, Ommen SR. Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy? Eur J Cardiothorac Surg. 2018 Mar 1; 53 (3):582-589
     View PubMed
143. Sims JR, Anavekar NS, Bhatia S, O'Horo JC, Geske JB, Chandrasekaran K, Wilson WR, Baddour LM, Gersh BJ, DeSimone DC. Clinical, Radiographic, and Microbiologic Features of Infective Endocarditis in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 Feb 15; 121 (4):480-484 Epub 2017 Nov 23
     View PubMed
144. Vallabhajosyula S, Jentzer JC, Geske JB, Kumar M, Sakhuja A, Singhal A, Poterucha JT, Kashani K, Murphy JG, Gajic O, Kashyap R. New-Onset Heart Failure and Mortality in Hospital Survivors of Sepsis-Related Left Ventricular Dysfunction. Shock. 2018 Feb; 49 (2):144-149
     View PubMed
145. Larsen CM, Ball CA, Hebl VB, Ong KC, Siontis KC, Olson TP, Ackerman MJ, Ommen SR, Allison TG, Geske JB. Effect of Body Mass Index on Exercise Capacity in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 Jan 1; 121 (1):100-106 Epub 2017 Oct 12
     View PubMed
146. Padang R, Gersh BJ, Ommen SR, Geske JB. Prevalence and Impact of Coexistent Bicuspid Aortic Valve in Hypertrophic Cardiomyopathy. Heart Lung Circ. 2018 Jan; 27 (1):33-40 Epub 2017 Mar 08
     View PubMed
147. Vallabhajosyula S, Sakhuja A, Geske JB, Kumar M, Kashyap R, Kashani K, Jentzer JC. Clinical profile and outcomes of acute cardiorenal syndrome type-5 in sepsis: An eight-year cohort study. PLoS One. 2018; 13 (1):e0190965 Epub 2018 Jan 09
     View PubMed
148. Ayoub C, Geske JB, Larsen CM, Scott CG, Klarich KW, Pellikka PA. Comparison of Valsalva Maneuver, Amyl Nitrite, and Exercise Echocardiography to Demonstrate Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy. Am J Cardiol. 2017 Dec 15; 120 (12):2265-2271 Epub 2017 Sept 19
     View PubMed
149. Geske JB, Ong KC, Siontis KC, Hebl VB, Ackerman MJ, Hodge DO, Miller VM, Nishimura RA, Oh JK, Schaff HV, Gersh BJ, Ommen SR. Women with hypertrophic cardiomyopathy have worse survival. Eur Heart J. 2017 Dec 7; 38 (46):3434-3440
     View PubMed
150. Tan NY, Zack CJ, Geske JB. 59-Year-Old Woman With Fatigue, Dyspnea, and Lower Extremity Edema. Mayo Clin Proc. 2017 Dec; 92 (12):e167-e171
     View PubMed
151. Cullen MW, Geske JB, Anavekar NS, Askew JW 3rd, Lewis BR, Oh JK. Handheld echocardiography during hospitalization for acute myocardial infarction. Clin Cardiol. 2017 Nov; 40 (11):993-999 Epub 2017 July 19
     View PubMed
152. Vallabhajosyula S, Sakhuja A, Geske JB, Kumar M, Poterucha JT, Kashyap R, Kashani K, Jaffe AS, Jentzer JC. Role of Admission Troponin-T and Serial Troponin-T Testing in Predicting Outcomes in Severe Sepsis and Septic Shock. J Am Heart Assoc. 2017 Sep 9; 6 (9) Epub 2017 Sept 09
     View PubMed
153. Vallabhajosyula S, Kumar M, Pandompatam G, Sakhuja A, Kashyap R, Kashani K, Gajic O, Geske JB, Jentzer JC. Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock: an 8-year historical cohort study. Ann Intensive Care. 2017 Sep 7; 7 (1):94 Epub 2017 Sept 07
     View PubMed
154. Abdelsalam MA, Geske JB. 77-year-old female with syncope. Heart. 2017 Feb 15; 103 (4):315 Epub 2016 Sept 23
     View PubMed
155. Bois JP, Geske JB, Foley TA, Ommen SR, Pellikka PA. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography. Am J Cardiol. 2017 Feb 15; 119: (4)643-650.
     View PubMed
156. Sugrue A, Killu AM, DeSimone CV, Chahal AA, Vogt JC, Kremen V, Hai J, Hodge DO, Acker NG, Geske JB, Ackerman MJ, Ommen SR, Lin G, Noseworthy PA, Brady PA. Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy. Open Heart. 2017; 4(1):e000561. Epub 2017 Feb 23.
     
157. Geske JB, Anavekar NS, Nishimura RA, Oh JK, Gersh BJ. Differentiation of Constriction and Restriction: Complex Cardiovascular Hemodynamics. J Am Coll Cardiol. 2016 Nov 29; 68 (21):2329-2347
     View PubMed
158. Prasad M, Geske JB, Sorajja P, Ommen SR, Schaff HV, Gersh BJ, Nishimura RA. Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction. Catheter Cardiovasc Interv. 2016 Nov 15; 88 (6):962-970 Epub 2016 Apr 06
     View PubMed
159. Konik E, Geske J, Edwards W, Gersh B. Pericardiectomy as a diagnostic and therapeutic procedure. BMJ Case Rep. 2016 Nov 14; 2016
     View PubMed
160. Orme NM, Geske JB, Pislaru SV, Askew JW, Lennon RJ, Lewis BR, Rihal CS, Pellikka PA, Singh M. Occupational musculoskeletal pain in cardiac sonographers compared to peer employees: a multisite cross-sectional study. Echocardiography. 2016 Nov; 33 (11):1642-1647 Epub 2016 Aug 20
     View PubMed
161. Smith SB, Geske JB, Kathuria P, Cuttica M, Schimmel DR, Courtney DM, Waterer GW, Wunderink RG. Analysis of National Trends in Admissions for Pulmonary Embolism. Chest. 2016 Jul; 150 (1):35-45 Epub 2016 Feb 18
     View PubMed
162. Geske JB, Pochettino A, Maltais S. Spontaneous resolution of iatrogenic ascending aorta dissection: now you see it, now you do not. Eur Heart J. 2016 Jul 1; 37 (25):1984 Epub 2016 May 08
     View PubMed
163. Thaden JJ, Sanon S, Geske JB, Eleid MF, Nijhof N, Malouf JF, Rihal CS, Bruce CJ. Echocardiographic and Fluoroscopic Fusion Imaging for Procedural Guidance: An Overview and Early Clinical Experience. J Am Soc Echocardiogr. 2016 Jun; 29 (6):503-12 Epub 2016 Mar 25
     View PubMed
164. Ong KC, Geske JB, Hebl VB, Nishimura RA, Schaff HV, Ackerman MJ, Klarich KW, Siontis KC, Coutinho T, Dearani JA, Ommen SR, Gersh BJ. Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2016 Jun; 17(6):604-10. Epub 2016 Feb 27.
     View PubMed
165. Boynton SJ, Geske JB, Dispenzieri A, Syed IS, Hanson TJ, Grogan M, Araoz PA. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2016 Jun; 9 (6):680-6 Epub 2016 May 18
     View PubMed
166. Widmer RJ, Engler NB, Geske JB, Klarich KW, Timimi FK. An Academic Healthcare Twitter Account: The Mayo Clinic Experience. Cyberpsychol Behav Soc Netw. 2016 Jun; 19 (6):360-6
     View PubMed
167. Osafo N, Goel K, Geske J. An unusual cause of syncope while gardening. Eur Heart J. 2016 May 14; 37 (19):1552 Epub 2016 Jan 26
     View PubMed
168. Pereira NL, Geske JB, Mayr M, Shah SH, Rihal CS. Pharmacogenetics of Clopidogrel: An Unresolved Issue. Circ Cardiovasc Genet. 2016 Apr; 9 (2):185-8
     View PubMed
169. Abdelsalam MA, Nippoldt TB, Geske JB. Acromegaly-induced cardiomyopathy with dobutamine-induced outflow tract obstruction. BMJ Case Rep. 2016 Mar 9; 2016 Epub 2016 Mar 09
     View PubMed
170. Hebl VB, Miranda WR, Ong KC, Hodge DO, Bos JM, Gentile F, Klarich KW, Nishimura RA, Ackerman MJ, Gersh BJ, Ommen SR, Geske JB. The Natural History of Nonobstructive Hypertrophic Cardiomyopathy. Mayo Clin Proc. 2016 Mar; 91 (3):279-87
     View PubMed
171. Newman DB, Miranda WR, Geske JB, Nishimura RA. Dynamic auscultation in hypertrophic obstructive cardiomyopathy: what can we learn from a murmur? Eur Heart J. 2016 Feb 01; 37: (5)498.
     View PubMed
172. Anderson MJ, Arruda-Olson A, Gersh B, Geske J. Subaortic membrane mimicking hypertrophic cardiomyopathy. BMJ Case Rep. 2015 Nov 4; 2015 Epub 2015 Nov 04
     View PubMed
173. Geske JB, Ommen SR. Role of imaging in evaluation of sudden cardiac death risk in hypertrophic cardiomyopathy. Curr Opin Cardiol. 2015 Sep; 30: (5)493-9.
     View PubMed
174. Miranda WR, Newman DB, Geske JB, Nishimura RA. An auscultatory conundrum: severe mitral stenosis with a third heart sound? Eur Heart J Cardiovasc Imaging. 2015 Aug; 16 (8):918 Epub 2015 Apr 29
     View PubMed
175. Towe E, Sharma S, Geske J, Ackerman MJ. Eccentric apical hypertrophic cardiomyopathy unmasked by multimodality imaging: an uncommon but missed cause of out of hospital cardiac arrest. BMJ Case Rep. 2015 Jul 6; 2015 Epub 2015 July 06
     View PubMed
176. Siontis KC, Geske JB, Gersh BJ. Atrial fibrillation pathophysiology and prognosis: insights from cardiovascular imaging. Circ Cardiovasc Imaging. 2015 Jun; 8: (6).
     View PubMed
177. Konecny T, Geske JB, Ludka O, Orban M, Brady PA, Abudiab MM, Albuquerque FN, Placek A, Kara T, Sahakyan KR, Gersh BJ, Tajik AJ, Allison TG, Ommen SR, Somers VK. Decreased exercise capacity and sleep-disordered breathing in patients with hypertrophic cardiomyopathy. Chest. 2015 Jun; 147 (6):1574-1581
     View PubMed
178. Geske JB, Evans TC Jr, Nishimura RA. Quantitative Cardiology: Back to Square One. J Heart Valve Dis. 2015 May; 24: (3)404.
     View PubMed
179. Coylewright M, Cabalka AK, Malouf JA, Geske JB, Pollak PM, Suri RM, Rihal CS. Percutaneous mitral valve replacement using a transvenous, transseptal approach: transvenous mitral valve replacement. JACC Cardiovasc Interv. 2015 May; 8 (6):850-857
     View PubMed
180. Geske JB, Evans TC Jr, Nishimura RA. Quantitative cardiology: back to square one. J Heart Valve Dis. 2014 Nov; 23(6):803.
     View PubMed
181. Ong KC, Geske JB, Klarich KW, Nishimura RA. A notch in time: midventricular hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2014 Nov; 15: (11)1288.
     View PubMed
182. Ong KC, Geske JB, Schaff HV, Nishimura RA. Transapical myectomy for severe mid-ventricular obstructive hypertrophic cardiomyopathy. Eur Heart J. 2014 Oct 14; 35: (39)2713.
     View PubMed
183. Haddad RA, Jouni H, Geske JB. Images in vascular medicine. Twenty-eight years later: A case of superior vena cava aneurysm secondary to cystic hygroma. Vasc Med. 2014 Oct; 19: (5)417-8.
     View PubMed
184. Geske JB, Konecny T, Ommen SR, Nishimura RA, Sorajja P, Schaff HV, Ackerman MJ, Gersh BJ. Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy. Eur Heart J. 2014 Aug 7; 35 (30):2032-9 Epub 2013 Dec 13
     View PubMed
185. Siontis KC, Geske JB, Ong K, Nishimura RA, Ommen SR, Gersh BJ. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. J Am Heart Assoc. 2014 Jun 25; 3 (3):e001002 Epub 2014 June 25
     View PubMed
186. Geske JB, Jouni H, Aubry MC, Gersh BJ. Fabry disease with resting outflow obstruction masquerading as hypertrophic cardiomyopathy. J Am Coll Cardiol. 2014 May 06; 63: (17)e43.
     View PubMed
187. Geske JB, Bos JM, Gersh BJ, Ommen SR, Eidem BW, Ackerman MJ. Deformation patterns in genotyped patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2014 Apr; 15: (4)456-65.
     View PubMed
188. Geske JB, Klarich KW, Ommen SR, Schaff HV, Nishimura RA. Septal reduction therapies in hypertrophic cardiomyopathy: Comparison of surgical septal myectomy and alcohol septal ablation. Interventional Cardiology (London). 2014; 6(2):199-215.
     
189. Geske JB, Scantlebury DC, Thomas JD, Nishimura RA. Hemodynamic evaluation of severe tricuspid regurgitation. J Am Coll Cardiol. 2013 Nov 12; 62: (20)e441.
     View PubMed
190. Scantlebury DC, Geske JB, Nishimura RA. Limitations of Doppler echocardiography in the evaluation of serial stenoses. Circ Cardiovasc Imaging. 2013 Sep; 6: (5)850-2.
     View PubMed
191. Jouni H, Geske JB, Miller TD. The diagnosis of apical hypertrophic cardiomyopathy with myocardial perfusion imaging. Heart. 2013 Jul; 99: (14)1064-5.
     View PubMed
192. Geske JB, McKie PM, Ommen SR, Sorajja P. B-type natriuretic peptide and survival in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013 Jun 18; 61 (24):2456-2460 Epub 2013 Apr 16
     View PubMed
193. Geske JB, Cullen MW, Hazin R, Malouf JF. Caught in the middle: apical ballooning syndrome with dynamic mid-ventricular obstruction. Eur Heart J Cardiovasc Imaging. 2013 Jun; 14: (6)605.
     View PubMed
194. Geske JB, Scantlebury DC, Nishimura RA. Doubly obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013 May 21; 61: (20)2107.
     View PubMed
195. Geske JB, Jouni H, Hoyt JR. Images in vascular medicine. The mystery of a crimson leg: a case of Klippel-Trenaunay-Weber syndrome. Vasc Med. 2013 Feb; 18(1):49-50. Epub 2012 Dec 21.
     View PubMed
196. Jouni H, Geske JB, Melduni RM. Diagnosis of achalasia on transthoracic echocardiography with the use of oral contrast. Circ J. 2013; 77 (8):2155-6 Epub 2013 Apr 17
     View PubMed
197. Geske JB, Cullen MW, Sorajja P, Ommen SR, Nishimura RA. Assessment of left ventricular outflow gradient: hypertrophic cardiomyopathy versus aortic valvular stenosis. JACC Cardiovasc Interv. 2012 Jun; 5 (6):675-81
     View PubMed
198. Geske JB, Smith SB, Morgenthaler TI, Mankad SV. Care of patients with acute pulmonary emboli: a clinical review with cardiovascular focus. Expert Rev Cardiovasc Ther. 2012 Feb; 10(2):235-50.
     View PubMed
199. Smith SB, Geske JB, Morgenthaler TI. Risk factors associated with delayed diagnosis of acute pulmonary embolism. J Emerg Med. 2012 Jan; 42(1):1-6. Epub 2011 Sep 29.
     View PubMed
200. Holmes DR, Geske JB, Eapen ZJ, Vavalle JP, Cullen MW, Desai NR. President's page: Wrinkling the Soul. J Am Coll Cardiol. 2011; 58(24):2542-3.
     
201. Geske JB, Barsness GW, Gulati R. Collateralization of an occluded left internal mammary artery coronary bypass graft. J Invasive Cardiol. 2011 Jul; 23: (7)E181-2.
     View PubMed
202. Geske JB, Sorajja P, Ommen SR, Nishimura RA. Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy. JACC Cardiovasc Interv. 2011 Jun; 4(6):704-9.
     View PubMed
203. Geske JB, Edwards WD, MacDonald RJ, Holmes DR Jr. Location of coronary culprit lesions at autopsy in 41 nondiabetic patients with acute myocardial infarction. Am J Forensic Med Pathol. 2010 Sep; 31(3):213-7.
     View PubMed
204. Widmer RJ, Geske JB, Clements IP. 40-year-old man with nausea and vomiting "found down". Mayo Clin Proc. 2010 Aug; 85 (8):e52-5
     View PubMed
205. Smith SB, Geske JB, Maguire JM, Zane NA, Carter RE, Morgenthaler TI. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest. 2010 Jun; 137 (6):1382-90 Epub 2010 Jan 15
     View PubMed
206. Calvin AD, Aggarwal NR, Murad MH, Shi Q, Elamin MB, Geske JB, Fernandez-Balsells MM, Albuquerque FN, Lampropulos JF, Erwin PJ, Smith SA, Montori VM. Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes. Diabetes Care. 2009 Dec; 32 (12):2300-6 Epub 2009 Sept 09
     View PubMed
207. Geske JB, Calvin AD. Spontaneous "cardiomegaly" following pericardiectomy. J Card Surg. 2009 Nov-Dec; 24: (6)695-6.
     View PubMed
208. Coss E, Geske JB, Mueller PS. 57-year-old woman with acute lower extremity pain and swelling. Mayo Clin Proc. 2009 Oct; 84 (10):e1-4
     View PubMed
209. Geske JB, Sorajja P, Nishimura RA, Ommen SR. The relationship of left atrial volume and left atrial pressure in patients with hypertrophic cardiomyopathy: an echocardiographic and cardiac catheterization study. J Am Soc Echocardiogr. 2009 Aug; 22: (8)961-6.
     View PubMed
210. Geske JB, Sorajja P, Ommen SR, Nishimura RA. Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy. Clin Cardiol. 2009 Jul; 32 (7):397-402
     View PubMed
211. Calvin AD, Geske JB, Bell MR. 69-year-old woman with rapid heartbeat. Mayo Clin Proc. 2008 Dec; 83(12):1392-5.
     View PubMed
212. Geske JB, Calvin AD, McDonald FS. 37-year-old man with painful foot. Mayo Clin Proc. 2008 Jul; 83: (7)821-4.
     View PubMed
213. Geske JB, Sorajja P, Nishimura RA, Ommen SR. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation. 2007 Dec 4; 116 (23):2702-8 Epub 2007 Nov 19
     View PubMed
214. Kostas TR, Jones DB, Schiefer TK, Geske JB, Carmichael SW, Pawlina W. The use of a video interview to enhance gross anatomy students' understanding of professionalism. Med Teach. 2007 Mar; 29 (2-3):264-6
     View PubMed
215. Geske JB, Goldstein RN, Stambler BS. Novel steerable telescoping catheter system for implantation of left ventricular pacing leads. J Interv Card Electrophysiol. 2005 Jan; 12 (1):83-9
     View PubMed